Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing the Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas on Urinary Albumin Excretion in People With Type 2 Diabetes Mellitus

NCT03983551 is registered in ClinicalTrials.gov with Changhua Christian Hospital as lead sponsor.

NCT NCT03983551
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03983551 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing the Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas on Urinary Albumin Excretion in People With Type 2 Diabetes Mellitus
Lead sponsor
Changhua Christian Hospital
Phase
Phase 4
Overall status
Completed
Start date
March 1, 2016
Completion date
February 28, 2018
Enrollment
101 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

proteinuria, type 2 diabetes mellitus